FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients
CAR-T therapy for blood cancers conventionally involves removing a patient’s immune cells, modifying them in a laboratory to attack cancer cells, and...
Search results for "T-cell lymphoma"
Boryung Completes Enrollment for Next-Gen Blood Cancer Drug Trial
Boryung announced on the 19th that it has completed patient enrollment for the Phase 2 clinical trial of its next-generation targeted cancer therapy...
GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval
GC Cell announced on Sept. 18 that South Korea’s Ministry of Food and Drug Safety has approved the compassionate use of...
Gachon University Gil Medical Center Expands Advanced Blood Cancer Care as Regional CAR-T Center Reaches Two-Year Milestone
For patients with aggressive blood cancers that recur or fail to respond to standard chemotherapy, chimeric antigen...
The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment
For patients diagnosed with aggressive blood cancers, receiving a proven targeted therapy offers a clear path toward a...
Celltrion Secures Historic FDA Interchangeability Status for Truxima
Celltrion announced on the 1st that the U.S. Food and Drug Administration has granted interchangeable status to Truxima...
Seoul St. Mary’s Hospital Wins 8 of 30 Awards at ICBMT 2026, Claiming Top Honors for Second Consecutive Year
The Catholic University of Korea’s Seoul St. Mary’s Hospital announced on the 20th that faculty members at its...
South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate
Curocell announced on Sept. 4 that its chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (generic name:...
HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data
HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical...
Mapping Cancer’s Footprint: Specialized PET/CT Scans Pinpoint Metastasis and Recurrence
Following a cancer diagnosis, patients and their families almost invariably ask the same urgent question: “How far has...